GeneReach Biotechnology Dividend
What is GeneReach Biotechnology current dividend yield, its reliability and sustainability?
Dividend Score 4/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
|GeneReach Biotechnology Dividend Yield vs Market|
|Market Bottom 25% (TW)||2.5%|
|Market Top 25% (TW)||6.9%|
|Industry Average (Medical Equipment)||3.9%|
|Analyst forecast in 3 Years (4171)||n/a|
Notable Dividend: 4171's dividend (8.9%) is higher than the bottom 25% of dividend payers in the TW market (2.54%).
High Dividend: 4171's dividend (8.9%) is in the top 25% of dividend payers in the TW market (6.9%)
Stability and Growth of Payments
|Month||Dividend Per Share (annual)||Avg. Yield (%)|
Stable Dividend: Too early to tell whether 4171's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if 4171's dividend payments are increasing as they only just started paying a dividend.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (61.9%), 4171's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (40.1%), 4171's dividend payments are well covered by cash flows.